Not provided
Not provided
Not provided
Not provided
Not provided
Failure to recruit patients
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The pathogenesis of AVN includes a defective blood supply to the knee joint. Local nitrates induce peripheral vasodilation and may improve blood supply to the affected tissue.
This study aims to test whether the use of a nicotine patch may accelerate the healing process from AVN of the knee.
The main purpose of this study is to examine whether treatment with a local nitrate patch will improve MRI findings and clinical outcomes in patients with AVN of the knee.
This is a double-blind prospective study that will include 50 adult volunteers, randomly assigned to a "nitrate" group that will be given a nitrate patch, and a "placebo" group that will be given a placebo patch.
The following outcomes will be measured:
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| study group | Experimental | the patients that will get a nitrate patch |
|
| control group | Placebo Comparator | the patients that will get the placebo patch |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| nitrate patch | Drug | patients in the study group will get a nitrate patch |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Reduction in bone substrate edema | the area and percent of the knee which the edema involves | 6 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| other MRI changes | reduction of subchondral fracture resolution of accompanied findings presence of femoral head or condyle flattening | 6 weeks |
| analgesics use | according to the patient's self report |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| avi livneh | Sheba Medical Center | Principal Investigator |
| arik asman, MD | Sheba Medical Center | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Sheba Medical Center | Ramat Gan | Israel |
Not provided
| ID | Term |
|---|---|
| D010020 | Osteonecrosis |
| ID | Term |
|---|---|
| D001847 | Bone Diseases |
| D009140 | Musculoskeletal Diseases |
| D009336 | Necrosis |
| D010335 | Pathologic Processes |
Not provided
Not provided
| ID | Term |
|---|---|
| D008279 | Magnetic Resonance Imaging |
| ID | Term |
|---|---|
| D014054 | Tomography |
| D003952 | Diagnostic Imaging |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| placebo patch |
| Drug |
control group patients will get a placebo patch |
|
|
| MRI scan | Device | MRI scan after 6 weeks of treatment |
|
|
| 6 weeks |
| pain severity | according to a visual analouge scale | 6 weeks |
| D013568 |
| Pathological Conditions, Signs and Symptoms |